While TG2, another transglutaminase isozyme, has been shown to reshape the tumor niche by regulating key signaling pathways and tissue biomechanics [18], TG7 may function similarly, possibly influencing cell adhesion, proliferation, or immunomodulation. Here, TGM2 is linked to neoplasm.